directCHECK ACT+ Whole Blood Control, Level 2

directCHECK GH100 ACT+L2 15/box

Registry build 21.09.26
3manufacturers in China registered for this device type
1catalogue number
2recalls on this code

Who Else Makes It

Concentrated in Shandong (2), Shanghai (1).

Chinese manufacturers registered for FDA product code GGN
Manufacturer City Province Registered as Device types
Infitek Co., Ltd. Shanghai Shanghai Manufacturer 49
Labpeak Co., Ltd. Jinan Shandong Manufacturer 43
Scitek Global Co., Ltd. Jinan Shandong Manufacturer 43

Record

Regulatory record for directCHECK ACT+ Whole Blood Control, Level 2
Listed by Accriva Diagnostics, Inc., United States
FDA product code GGN
Device type Plasma, Coagulation Control
Device class Class 2
Regulation 21 CFR 864.5425
Establishment Contract manufacturer, Manufacturer, Exporter
510(k) K202101
Record published 2022-01-21
Record revised 2026-05-18 (version 3)

Specifications

Specifications
MRI safety Labeling does not contain MRI Safety Information
Single use Yes
Prescription Prescription only
Label carries lot or batch number, expiry date
Storage Storage environment temperature 2 to 8 °C
UDI direct marking Exempt

Catalogue Numbers

Catalogue numbers for directCHECK ACT+ Whole Blood Control, Level 2
Catalogue number Size Per pack Status
000DCGACT-2 15 In distribution

Same Product Code

Other products under the same FDA product code
Product Sold by Catalogue numbers
George King Pooled Normal Plasma George King BIO-Medical, Inc. 15
directCHECK Whole Blood Controls Accriva Diagnostics, Inc. 12
Thermo Scientific Pacific Hemostasis® Fisher Diagnostics 8
Lyphochek Bio-Rad Laboratories Inc. 8
George King Single Donor Normal Plasma George King BIO-Medical, Inc. 7
Validate LGC Clinical Diagnostics, Inc. 6
George King Coumadin® Plasma George King BIO-Medical, Inc. 5
Plasma, Coagulation Control Medtronic, Inc. 5
Liquichek Bio-Rad Laboratories Inc. 5
CueSee® Coag Eurotrol B.V. 5
Rotem® TEM Innovations GmbH 4
CRYOcheck™ Pooled Normal Plasma Precision BioLogic Inc. 4

Showing 12 of 129. All products under Plasma, Coagulation Control

Recalls Naming This Product

1 recall names this product by its own identifier, the 510(k) it is cleared under.

Recalls naming the identifiers of directCHECK ACT+ Whole Blood Control, Level 2
Recalled by Identified by Initiated FDA class Root cause Reason Quantity
Accriva Diagnostics, Inc. 510(k) number 2026-04-30 Class II Process control Assayed Whole blood control contains labeling with incorrect performance range. 6060

Recalls

The FDA has not published a severity grade for these. Volume alone is not a quality signal: a manufacturer that ships more recalls more.

Recalls referencing this product code
Initiated FDA class Root cause Reason Quantity Closed
2010-04-15 Not classified Error in labeling Indication not cleared or approved. The acceptable performance range published in the directCHECK Microcoagulation Quality Control package insert is incorrect. 94 boxes 2010-09-23

Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.

Where China Actually Supplies

Every device page names the company that lists it and the factories registered to make the same thing. These are the sections with the most of them.

5,100manufacturers registered in China
2,581device types they are registered for
340,248device records, each naming its maker
31provinces with a registered manufacturer